---
company: KORU Medical Systems, Inc.
ticker: KRMD
form: 8-K
filed: 2026-11-10
accepted: 2026-11-10T21:43:30+00:00
accession: 0001161697-26-000243
source: https://www.sec.gov/Archives/edgar/data/704440/000116169726000243/
---

# KORU Medical Systems (KRMD) Q3 2026 earnings

## Header

- Company: KORU Medical Systems, Inc.
- Reported: 2026-11-10 16:43 AMC ET
- Source: 8-K only — accession 0001161697-26-000243, Item 2.02 + Exhibit 99.1
- Verdict: Revenue grew 12.4% year-over-year to $31.4 million, but adjusted EBITDA margin contracted by 2.2 percentage points to 13.9%.

## Headline numbers

| Metric | Actual | YoY | QoQ | 8-K location |
|---|---:|---:|---:|---|
| Revenue | $31.4 million | +12.4% | +4.9% | Ex. 99.1, Financial Highlights |
| EPS (GAAP) | $0.03 | +0.01 | +0.01 | Ex. 99.1, Financial Highlights |
| EPS (adjusted) | $0.05 | +0.01 | +0.01 | Ex. 99.1, Financial Highlights |
| Net income | $2.1 million | +0.7 million | +0.7 million | Ex. 99.1, Financial Highlights |
| Adj. EBITDA | $4.4 million | +0.5 million | +0.2 million | Ex. 99.1, Financial Highlights |
| Adj. EBITDA margin | 13.9% | -2.2 pp | -0.5 pp | Ex. 99.1, Financial Highlights |

## Revenue breakdown

| Segment | Actual | YoY | Share of revenue | Note |
|---|---:|---:|---:|---|
| North America | $17.4 million | +13.7% | 55% | — |
| International | $14.0 million | +10.9% | 45% | — |

## Margins and costs

- Gross margin: 53.8% (prior 54.5%, change -0.7 pp)
- Operating expenses: $14.4 million (+11.2% YoY)
- One-offs in the quarter: Tax benefit of $0.3 million related to foreign tax credit carryforwards; Restructuring charges of $0.2 million
- Effective tax rate: 20.0% (prior-year 20.0%, year-to-date 20.0%)
- Non-GAAP bridge: Adds back stock-based compensation ($0.8 million) and restructuring charges ($0.2 million).

## KPIs

| Metric | Actual | Prior quarter | Prior year | Change |
|---|---:|---:|---:|---:|
| Free cash flow | $2.8 million | $2.6 million | $2.5 million | +0.2 million |
| Days sales outstanding | 48 days | 49 days | 50 days | -1 day |
| Cash and cash equivalents | $25.4 million | $22.8 million | $21.9 million | +2.6 million |

## Guidance

| Metric | Guide | Prior guide | Change |
|---|---:|---:|---|
| Revenue | $30.0 million - $32.0 million | $30.0 million - $32.0 million | — |
| Adjusted EBITDA | $3.5 million - $4.5 million | $3.5 million - $4.5 million | — |

## What drove it

- Revenue story: Revenue grew 12.4% year-over-year, driven by 13.7% growth in North America and 10.9% growth in International.
- EPS story: Adjusted EPS increased by $0.01 year-over-year, driven by higher revenue and a lower tax rate.
- One-off check: Tax benefit of $0.3 million related to foreign tax credit carryforwards and restructuring charges of $0.2 million.

## The good

- Revenue growth of 12.4% year-over-year
- Adjusted EBITDA of $4.4 million
- Free cash flow of $2.8 million

## The bad

- Adjusted EBITDA margin contracted by 2.2 percentage points year-over-year
- Operating expenses increased 11.2% year-over-year

## The ugly

- none

## Open questions

- What specific factors drove the 11.2% increase in operating expenses?
- Why did the adjusted EBITDA margin contract despite revenue growth?

## Full release

### KORU Medical Systems (KRMD) earnings release, November 10, 2026

KORU Medical Systems, Inc. (KRMD) · Form 8-K, Item 2.02 · Filed 2026-11-10 · [SEC filing](https://www.sec.gov/Archives/edgar/data/704440/000116169726000243/)

Attachments

Seq Document Description

───────────────────────────────────────────────────────────────────────────────

2 ex_99-1.htm PRESS RELEASE, DATED NOVEMBER 10, 2026
